Literature DB >> 31150164

Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.

Esther Diana Rossi1, William C Faquin2, Liron Pantanowitz3.   

Abstract

Certain carcinomas of the thyroid gland behave aggressively resulting in increased patient morbidity and poor patient prognosis. The diagnosis of these aggressive thyroid cancer subtypes is sometimes challenging and subject to increased interobserver variability. This review deals with the cytological features of such tumors including aggressive variants of papillary thyroid carcinoma, poorly differentiated thyroid carcinoma, and anaplastic thyroid carcinoma. These malignancies fall into 2 groups based on their cytomorphology: those that exhibit distinct microscopic features (eg, nuclear findings typical of classical papillary thyroid carcinoma or marked anaplasia) and those that present with more subtle cytologic features (eg, nuclear pseudostratification, "soap bubble" nuclei, supranuclear or subnuclear cytoplasmic vacuoles, rosette-like structures, hobnail cells). We review the literature regarding these aggressive thyroid cancers and highlight important phenotypic characteristics that can be useful for their diagnosis based on fine needle aspiration.
© 2019 American Cancer Society.

Entities:  

Keywords:  aggressive variants; anaplastic carcinoma; fine needle aspiration cytology; personalized medicine; poorly differentiated carcinoma; thyroid cancer

Year:  2019        PMID: 31150164     DOI: 10.1002/cncy.22136

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  7 in total

Review 1.  Aggressive variants of follicular cell-derived thyroid carcinoma: an overview.

Authors:  Cristina Pizzimenti; Vincenzo Fiorentino; Antonio Ieni; Maurizio Martini; Giovanni Tuccari; Maria Lentini; Guido Fadda
Journal:  Endocrine       Date:  2022-07-21       Impact factor: 3.925

2.  Cytomorphologic features as predictors of aggressiveness in patients with pT1 papillary thyroid carcinoma: a retrospective study of associations with clinicopathological parameters in 226 fine-needle aspirates.

Authors:  Yanli Zhu; Wenhao Ren; Yuntao Song; Zhihui Fan; Qian Wang; Haizhu Jin; Yiyi Guo; Yanhua Bai
Journal:  Gland Surg       Date:  2021-01

3.  High-grade mucoepidermoid carcinoma in the thyroid gland with poor prognosis.

Authors:  Hyeong Chan Shin
Journal:  Yeungnam Univ J Med       Date:  2021-03-05

4.  Cytomorphological study of thyroid carcinoma.

Authors:  Iuliana Mohorea; Dana Terzea; Daniela Mihalache; Bogdan Socea; Dragoş Şerban; Mihai Ceausu
Journal:  Exp Ther Med       Date:  2021-12-06       Impact factor: 2.447

5.  Does Locally Advanced Thyroid Cancer Have Different Features? Results from a Single Academic Center.

Authors:  Marco Dell'Aquila; Pietro Tralongo; Giuseppe De Ruggieri; Mariangela Curatolo; Luca Revelli; Celestino Pio Lombardi; Alfredo Pontecorvi; Guido Fadda; Luigi Maria Larocca; Marco Raffaelli; Liron Pantanowitz; Esther Diana Rossi
Journal:  J Pers Med       Date:  2022-02-05

6.  Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).

Authors:  Liang Shi; Qinqin You; Jun Wang; Hanjin Wang; Shaohua Li; Rui Tian; Xiaocheng Yao; Wenyu Wu; Lele Zhang; Feng Wang; Yansong Lin; Shuren Li
Journal:  Endocrine       Date:  2022-06-29       Impact factor: 3.925

7.  Pseudogene legumain promotes thyroid carcinoma progression via the microRNA-495/autophagy pathway.

Authors:  Jie Sun; Yicheng Peng; Jianxia Liu; Hao Zhou; Liang Sun; Qin He; Enqiao Yu
Journal:  Oncol Lett       Date:  2021-06-24       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.